For a change, let’s hear some good news from the United Kingdom after a month that saw two terrorist attacks and now a tragic apartment fire in London where casualties are mounting as we speak.
The good news is that cannabinoid biotechnology company MediPen Ltd. is launching its own dedicated marijuana research facility this summer, and it will provide a platform for anyone looking to utilize its 1,800 square-foot facilities for the purposes of innovation in the area of medicinal cannabis.
As the first biotechnology company to develop a vapor product, MediPen Ltd. has already enjoyed success selling their non-psychoactive CBD vaporizers, which are currently in the process of securing a license from the British Home Office.
Their goal is to import and work with controlled compounds, including THC, for further research.
MediPen intends to further study vaporizers to treat cancer patients with the aim of minimizing the negative impact of chemotherapy-based treatments, such as nausea and vomiting, as well as attempting to suppress metastasis through inhibiting the proliferation of cancer cells.
Among the most respected legal cannabinoid providers in the UK, last summer MediPen entered into a contract with the country’s National Health Service (NHS) to improve the quality and safety of cannabinoid goods all around.
Their devices were tested by an NHS unit, an unprecedented and important step that helped focus and increase attention on the medical benefits of cannabis.
“As it stands, there is a significant amount of scientific data available detailing the powerful effects of cannabinoids within cell culture systems and in vivo,” a MediPen representative told the Independent. “However, we plan to be amongst the first in the world to begin clinical trials on humans.”
While GW Pharmaceuticals is also developing CBD-based medicine from its own facility, MediPen’s will be a little different in terms of its public availability.
MediPen intends to allow the use of its facilities to founders of other cannabis-based innovations, who will also be encouraged to take advantage of their established R&D network, state of the art, in-house testing, as well as on-board business and legal advice.
How Sharmila Clee Got Off Valium With Plant-Assisted Therapy
Pennsylvania Senators Seeking Co-Sponsors for Recreational Cannabis Bill
Researchers Launching CBD Study with Former Hockey Players
New Jersey Lawmakers Begin Hearings for Marijuana Legalization
Knowledgeable Dabbing: A Guide To Our Favorite Quartz Bangers
First Clinical Trial Of Cannabis For PTSD in Veterans Is Now Complete
Missouri Police Raid Hospital Room of Stage 4 Cancer Patient Using Cannabis
Oklahoma House Passes Medical Cannabis Protection Bill
News4 days ago
Indiana State Trooper Seizes $3.5 Million Worth of Cannabis, Vapes
News4 days ago
Colorado Researchers Seeking Volunteers to Get High and Drive
News5 days ago
Study Finds Medical Marijuana Alleviates Seniors’ Pain, Reduces Opioid Use
News6 days ago
Survey Shows 25% of Cannabis Users in Legal States Consume at Work
Legalization5 days ago
Breaking: Connecticut Lawmakers Unveil Plan to Legalize Marijuana
News7 days ago
NJ Governor Announces Vote on Marijuana Legalization This Month
Culture7 days ago
What’s In Your Stash? Cannabis Alchemist Warren Bobrow
Culture3 days ago
The New “Miss Marijuana” Pageant Comes With Outdated Guidelines and Transphobia